Remarkably, modulation of AhR activity by small molecules alters vital signaling pathways associated with cancer development and progression such as Wnt/β-catenin [30], PI3K/AKT [33], and mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) [34] signaling pathways. This evidence concerns the gene AHR and cancer.